News & Events
Liquidity of mid-cap AIM stocks diminishing post MiFID II- Investment Week
Mike Sheen of Investment Week features Hardman & Co MiFID II Monitor data highlight drop in liquidity and research coverage.
Hardman & Co Quarterly Newsletter
It has been a busy year at Hardman & Co, we have welcomed new team members, new clients, and given our brand a makeover. 2018 has also been a landmark year for us, celebrating 21 years in business. The launch of our MiFID II Monitor We have launched the MiFIDII monitor, designed to track the […]
Tony Williams quoted in Investors Chronicle: ‘Bargain Shares: Repeating buying opportunities’
Titon named as one of the ten small-cap companies to make Simon Thompson’s 2018 Bargain Shares Portfolio.
Evening Standard feature Dr Martin Hall on the Advanced Oncotherapy investment story
‘Market Minnows: Cancer firm Advanced Oncotherapy might be a long-term winner’.
Introducing our new look
Something brand new from Hardman & Co.
Governance in the world of business relief
Advisers need to look at the quality of governance behind business relief products.
Bloomberg feature Keith Hiscock on the rise of sponsored research post MiFID II
Keith Hiscock says revenue from its sponsored segment has grown 50 percent in the first half from the previous year.
Dr Brian Moretta on Estate Planning and IHT
Dr Brian Moretta on the Adviser Hour by GrowthInvest, panel discussion on estate planning and IHT, including current government led overview of the market.
Bloomberg interview Keith Hiscock on MiFID II Monitor findings
‘For smaller companies, the concern is that declining coverage also curbs trading volumes, making it harder for them to raise capital, transfer stakes or meet institutional investors’ liquidity requirements.’
Twitter latest
- Hardman referred to in the Yorkshire Post: 'Small and mid sized firms need their winter flu jab' Read more at: https://t.co/21hH808n2g'